Macugen News
Most Popular Macugen Story
OSI looks to unload Macugen, exit eye diseases
Just a year after buying Macugen from Eyetech (a 2003 Fierce 15 company), OSI Pharmaceuticals is looking for a way out of the eye disease sector. The company reports that it is exploring licensing or selling Macugen and its research assets in the field. Analysts expect OSI to shift its attention to its pipeline, which includes a promising therapy for …
Read more...Latest Headlines
- January 4, 2007
- November 6, 2006
- October 29, 2006
- July 2, 2006
- February 28, 2006
- November 10, 2005
- September 6, 2005
- August 31, 2005
- August 21, 2005
- June 21, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
